73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Targeting a unique metabolic pathway might starve pancreatic cancer

Targeting a unique metabolic pathway might starve pancreatic cancer

by Nancy Fliesler and Andrea Tamayo,Broad Institute of MIT and HarvardMItochondrial staining (red) and nuclear staining (blue) of abnormal pancreatic ducts from a mouse model of human pancreatic

Targeting a unique metabolic pathway might starve pancreatic cancer

by Nancy Fliesler and Andrea Tamayo,Broad Institute of MIT and HarvardMItochondrial staining (red) and nuclear staining (blue) of abnormal pancreatic ducts from a mouse model of human pancreatic
Occupational exposure to solar UVR linked to nonmelanoma skin cancer

Occupational exposure to solar UVR linked to nonmelanoma skin cancer

by Elana GotkineOccupational exposure to solar ultraviolet radiation (UVR) is associated with a substantial burden of nonmelanoma skin cancer (NMSC), according to a study published in the November iss

Occupational exposure to solar UVR linked to nonmelanoma skin cancer

by Elana GotkineOccupational exposure to solar ultraviolet radiation (UVR) is associated with a substantial burden of nonmelanoma skin cancer (NMSC), according to a study published in the November iss
Study quantifies impact of NCI-sponsored trials on clinical cancer care

Study quantifies impact of NCI-sponsored trials on clinical cancer care

by National Cancer InstituteA study shows that 82 of 182 phase 3 clinical trials led by SWOG or by other NCTN groups with SWOG participation were 'practice influential'. Credit: National

Study quantifies impact of NCI-sponsored trials on clinical cancer care

by National Cancer InstituteA study shows that 82 of 182 phase 3 clinical trials led by SWOG or by other NCTN groups with SWOG participation were 'practice influential'. Credit: National
Cancer cell repopulation after therapy: Study explores the mechanism

Cancer cell repopulation after therapy: Study explores the mechanism

by Impact Journals LLCPresumed models of tumor cell repopulation after escaping chemoradiation. Credit: 2023 Prakash and TelleriaThe past two decades have brought great progress in the treatment of ca

Cancer cell repopulation after therapy: Study explores the mechanism

by Impact Journals LLCPresumed models of tumor cell repopulation after escaping chemoradiation. Credit: 2023 Prakash and TelleriaThe past two decades have brought great progress in the treatment of ca
Solving the mystery of NPM1 in acute myeloid leukemia

Solving the mystery of NPM1 in acute myeloid leukemia

by Allison Mickey,Baylor College of MedicineDr. Margaret Goodell, the corresponding author of this work. Credit: Baylor College of MedicineAlthough it has long been recognized that mutations of

Solving the mystery of NPM1 in acute myeloid leukemia

by Allison Mickey,Baylor College of MedicineDr. Margaret Goodell, the corresponding author of this work. Credit: Baylor College of MedicineAlthough it has long been recognized that mutations of
Clinical trial suggests new cell therapy for relapsed leukemia patients

Clinical trial suggests new cell therapy for relapsed leukemia patients

by Stanford University Medical CenterA Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaA significant

Clinical trial suggests new cell therapy for relapsed leukemia patients

by Stanford University Medical CenterA Wright's stained bone marrow aspirate smear from a patient with precursor B-cell acute lymphoblastic leukemia. Credit: VashiDonsk/WikipediaA significant
New study shows patient/clinician identity differences are a factor in cancer care

New study shows patient/clinician identity differences are a factor in cancer care

byJohns Hopkins University School of MedicineCredit: Unsplash/CC0 Public DomainA new study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with Dell Medical School, Uni

New study shows patient/clinician identity differences are a factor in cancer care

byJohns Hopkins University School of MedicineCredit: Unsplash/CC0 Public DomainA new study by researchers at the Johns Hopkins Kimmel Cancer Center in collaboration with Dell Medical School, Uni
Study provides new guidelines for assessing severity of head and neck cancers

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head

Study provides new guidelines for assessing severity of head and neck cancers

by Cedars-Sinai Medical Center'The greater the number of malignant lymph nodes, the less favorable the patients' chances of survival,' said Allen S. Ho, MD. Ho is director of the Head
Cancer cells can reuse apparent 'dead end metabolites'

Cancer cells can reuse apparent 'dead end metabolites'

by Quinn Eastman,Emory UniversityThe oxidative pentose phosphate pathway gives cancer cells both cellular building blocks for rapid growth and a critical internal antioxidant called NADPH. 6-pho

Cancer cells can reuse apparent 'dead end metabolites'

by Quinn Eastman,Emory UniversityThe oxidative pentose phosphate pathway gives cancer cells both cellular building blocks for rapid growth and a critical internal antioxidant called NADPH. 6-pho
Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi

Study: GPs managing more skin cancer cases as cost of treatment climbs in Australia

by University of Sydney(A) Proportion of different skin cancer-related conditions managed in general practice, 2000–2016. (B) Management rate per 1,000 encounters of all skin cancer-related condi
Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l

Using donor CAR T cells shows promise in treating myeloma patients in phase I trial

by Bob Yirka , Medical XpressCAR T Cell Concentrations Stratified by Response. (a) CAR T cell concentrations among ALLO-715 DL3 patients that received any fludarabine/cyclophosphamide/ALLO-647 (FCA) l
Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be

Immune and tumor cell 'tug-of-war' controls anti-cancer activity, study finds

bySt. Jude Children's Research HospitalIntratumoral glutamine supplementation promotes cDC1-mediated anti-tumor immunity.a, Levels of glutamine and glucose in plasma and TIF of mice be